These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38372246)

  • 1. Hybrid Closed-Loop Versus Manual Insulin Delivery in Adults With Type 1 Diabetes: A Post Hoc Analysis Using the Glycemia Risk Index.
    Lee MH; Vogrin S; Jones TW; O'Neal DN
    J Diabetes Sci Technol; 2024 Jul; 18(4):764-770. PubMed ID: 38372246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Glycemia Risk Index with Time in Range for Assessing Glycemic Quality.
    Kim JY; Yoo JH; Kim JH
    Diabetes Technol Ther; 2023 Dec; 25(12):883-892. PubMed ID: 37668665
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of Glycemia Risk Index and Standard Continuous Glucose Monitoring Metrics in a Real-World Setting of Exercise in Adults With Type 1 Diabetes: A Post-Hoc Analysis of the Type 1 Diabetes and Exercise Initiative.
    Morrison D; Vogrin S; Zaharieva DP
    J Diabetes Sci Technol; 2024 Jul; 18(4):787-794. PubMed ID: 38629861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact on Glycemia Risk Index and other metrics in type 1 adult patients switching to Advanced Hybrid Closed-Loop systems: a one-year real-life experience.
    Resmini E; Zarra E; Dotti S; Rotondi G; Cornaghi AV; Madaschi S; Cimino E; Massari G; Pezzaioli LC; Buoso C; Sandri M; Girelli A
    Eur J Med Res; 2024 Jul; 29(1):365. PubMed ID: 39004734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of glucose variability on the assessment of the glycemia risk index (GRI) and classic glycemic metrics.
    Pérez-López P; Férnandez-Velasco P; Bahillo-Curieses P; de Luis D; Díaz-Soto G
    Endocrine; 2023 Dec; 82(3):560-568. PubMed ID: 37695452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial.
    McAuley SA; Lee MH; Paldus B; Vogrin S; de Bock MI; Abraham MB; Bach LA; Burt MG; Cohen ND; Colman PG; Davis EA; Hendrieckx C; Holmes-Walker DJ; Kaye J; Keech AC; Kumareswaran K; MacIsaac RJ; McCallum RW; Sims CM; Speight J; Stranks SN; Sundararajan V; Trawley S; Ward GM; Jenkins AJ; Jones TW; O'Neal DN;
    Diabetes Care; 2020 Dec; 43(12):3024-3033. PubMed ID: 33055139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Glucose Control With a Novel Composite Continuous Glucose Monitoring Index.
    Leelarathna L; Thabit H; Wilinska ME; Bally L; Mader JK; Pieber TR; Benesch C; Arnolds S; Johnson T; Heinemann L; Hermanns N; Evans ML; Hovorka R
    J Diabetes Sci Technol; 2020 Mar; 14(2):277-283. PubMed ID: 30931606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid Closed Loop Using a Do-It-Yourself Artificial Pancreas System in Adults With Type 1 Diabetes.
    Nanayakkara N; Sharifi A; Burren D; Elghattis Y; Jayarathna DK; Cohen N
    J Diabetes Sci Technol; 2024 Jul; 18(4):889-896. PubMed ID: 36788715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic variability through the perspective of the glycemia risk index and time in range and their association with glycated hemoglobin A1c in pediatric patients on sensor-augmented pump therapy.
    Bukara-Radujkovic G; Miljkovic V
    Front Endocrinol (Lausanne); 2024; 15():1388245. PubMed ID: 38957442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.
    Swami V; Yadav SK; Saxena P; Sharma A; Dash CK; Gupta A
    J Assoc Physicians India; 2024 Jan; 72(1):18-21. PubMed ID: 38736069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing Glycemic Control and Sleep in Adults with Long-Standing Type 1 Diabetes and Hypoglycemia Unawareness Initiating Hybrid Closed Loop Insulin Delivery.
    Malone SK; Peleckis AJ; Grunin L; Yu G; Jang S; Weimer J; Lee I; Rickels MR; Goel N
    J Diabetes Res; 2021; 2021():6611064. PubMed ID: 33628834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.
    Abraham MB; de Bock M; Smith GJ; Dart J; Fairchild JM; King BR; Ambler GR; Cameron FJ; McAuley SA; Keech AC; Jenkins A; Davis EA; O'Neal DN; Jones TW;
    JAMA Pediatr; 2021 Dec; 175(12):1227-1235. PubMed ID: 34633418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poincaré plot quantification for assessing glucose variability from continuous glucose monitoring systems and a new risk marker for hypoglycemia: application to type 1 diabetes patients switching to continuous subcutaneous insulin infusion.
    Crenier L
    Diabetes Technol Ther; 2014 Apr; 16(4):247-54. PubMed ID: 24237387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemia Risk Index as a Novel Metric to Evaluate the Safety of Glycemic Control in Children and Adolescents with Type 1 Diabetes: An Observational, Multicenter, Real-Life Cohort Study.
    Piona C; Marigliano M; Roncarà C; Mozzillo E; Di Candia F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Passanisi S; Lombardo F; Bonfanti R; Maffeis C
    Diabetes Technol Ther; 2023 Jul; 25(7):507-512. PubMed ID: 37155332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of Two Hybrid Closed-Loop Systems in Italian Children and Adults With Type 1 Diabetes.
    Bassi M; Teliti M; Lezzi M; Iosca A; Strati MF; Carmisciano L; d'Annunzio G; Minuto N; Maggi D
    Front Endocrinol (Lausanne); 2021; 12():802419. PubMed ID: 35116007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
    Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
    Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Glycemic Outcomes During the MiniMed
    Pihoker C; Shulman DI; Forlenza GP; Kaiserman KB; Sherr JL; Thrasher JR; Buckingham BA; Kipnes MS; Bode BW; Carlson AL; Lee SW; Latif K; Liljenquist DR; Slover RH; Dai Z; Niu F; Shin J; Jonkers RAM; Roy A; Grosman B; Vella M; Cordero TL; McVean J; Rhinehart AS; Vigersky RA;
    Diabetes Technol Ther; 2023 Nov; 25(11):755-764. PubMed ID: 37782145
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in the glycaemia risk index and its association with other continuous glucose monitoring metrics after initiation of an automated insulin delivery system in adults with type 1 diabetes.
    Karakus KE; Shah VN; Klonoff D; Akturk HK
    Diabetes Obes Metab; 2023 Nov; 25(11):3144-3151. PubMed ID: 37427768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-Month Effectiveness of Advanced
    Tornese G; Buzzurro F; Carletti C; Faleschini E; Barbi E
    Front Endocrinol (Lausanne); 2021; 12():766314. PubMed ID: 34858339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.